GL1X · GenesisL1 explorer

MolNFT v1 · #62669 · protein

Discovery and sar of novel 4-thiazolyl-2- phenylaminopyrimidines as potent inhibitors of spleen tyrosine kinase (syk)

3EMG · Tyrosine-protein kinase syk: “Discovery and sar of novel 4-thiazolyl-2- phenylaminopyrimidines as potent inhibitors of spleen tyrosine…”. X-ray diffraction, 1 ligand (685), 2 pockets (best druggability 0.62). MolNFT v1 #62669 on…

PDB
3EMG
Type
protein
Length
255 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Tyrosine-protein kinase syk
EC
2.7.10.2
UniProt
P43405
Ligands
685
Pockets
2 · best druggability 0.62

Structure

x-ray diffraction · 1 distinct chain · 39% helix, 22% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ATyrosine-protein kinase syk (EC 2.7.10.2)protein25539% helix, 22% strandP43405

Ligands and binding sites

  • 685 · 2-{2-[(3,5-dimethylphenyl)amino]pyrimidin-4-yl}-N-[(1S)-2-hydroxy-1-methylethyl]-4-methyl-1,3-thiazole-5-carboxamide · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13470.620.7840685
2520.280.7517empty

Compared structures

  • 3EMG · Discovery and SAR of novel 4-thiazolyl-2-phenylaminopyrimidines as potent inhibitors of… · the same entry in another collection · chain A against A, TM-score 1.00
  • P43405 · AlphaFold monomer V2.0 prediction for tyrosine-protein kinase syk (P43405) · a predicted model of the same protein · chain A against A, TM-score 0.91

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.